Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multinational, Multicentre, Double-blind, Placebo-controlled Evaluation of the Efficacy of GHB in the Long-term Maintenance of Abstinence in Alcoholic Patients After the Initial Weaning Phase, Stratified by Lesch's Taxonomy (GATE 2)

NCT04648423 is registered in ClinicalTrials.gov with Laboratorio Farmaceutico Ct S.r.l. as lead sponsor.

NCT NCT04648423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04648423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multinational, Multicentre, Double-blind, Placebo-controlled Evaluation of the Efficacy of GHB in the Long-term Maintenance of Abstinence in Alcoholic Patients After the Initial Weaning Phase, Stratified by Lesch's Taxonomy (GATE 2)
Lead sponsor
Laboratorio Farmaceutico Ct S.r.l.
Phase
Phase 4
Overall status
Completed
Start date
July 23, 2001
Completion date
January 31, 2012
Enrollment
314 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol dependence, alcohol use disorder (aud)